Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia

Antipsychotic Treatment of Acute Paranoid Schizophrenia Patients with Olanzapine Results in Altered Glycosylation of Serum Glycoproteins

(2012) Jayne E. Telford et al.   JOURNAL OF PROTEOME RESEARCH

Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls

(2012) Julian A.J. Jaros et al.   Journal of Proteomics

Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry

(2012) Julian A.J. Jaros et al.   Journal of Proteomics

Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia

(2012) Yang Li et al.   Molecular BioSystems

Risk of venous thromboembolism during treatment with antipsychotic agents

(2012) Jiří Masopust et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Secreted Kinase Phosphorylates Extracellular Proteins That Regulate Biomineralization

(2012) V. S. Tagliabracci et al.   SCIENCE

Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients

(2011) Julian A. J. Jaros et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Plasma gelsolin: A general prognostic marker of health

(2011) Nagesh Peddada et al.   MEDICAL HYPOTHESES

Identification of a biological signature for schizophrenia in serum

(2011) E Schwarz et al.   MOLECULAR PSYCHIATRY

Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage

(2010) Ann K. Rosenthal et al.   ARTHRITIS AND RHEUMATISM

Identification of Tyr438 as the major in vitro c-Src phosphorylation site in human gelsolin: A mass spectrometric approach

(2010) Veerle De Corte et al.   PROTEIN SCIENCE

Antipsychotic drugs and obesity

(2010) Christoph U. Correll et al.   TRENDS IN MOLECULAR MEDICINE

Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study

(2009) Jonathan M. Meyer et al.   BIOLOGICAL PSYCHIATRY

Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects

(2009) Kwang H Choi et al.   BMC Psychiatry

Analysis of Flagellar Phosphoproteins fromChlamydomonas reinhardtii

(2009) Jens Boesger et al.   EUKARYOTIC CELL

A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

(2009) John W. Newcomer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effect of Antipsychotics on Peptides Involved in Energy Balance in Drug-Naive Psychotic Patients After 1 Year of Treatment

(2009) Rocio Perez-Iglesias et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Multidimensional protein fractionation of blood proteins coupled to data-independent nanoLC–MS/MS analysis

(2009) Yishai Levin et al.   Journal of Proteomics

Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures

(2009) Guo-Zhong Li et al.   PROTEOMICS

Multiple Testing with Minimal Assumptions

(2008) Peter H. Westfall et al.   BIOMETRICAL JOURNAL

Analysis of the trypanosome flagellar proteome using a combined electron transfer/collisionally activated dissociation strategy

(2008) Sarah R. Hart et al.   JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver

(2008) Johan Fernø et al.   PSYCHOPHARMACOLOGY

Observational Research, Randomised Trials, and Two Views of Medical Science

(2008) Jan P Vandenbroucke   PLOS MEDICINE

False Discovery Rates and Related Statistical Concepts in Mass Spectrometry-Based Proteomics

(2007) Hyungwon Choi et al.   JOURNAL OF PROTEOME RESEARCH